(NASDAQ: TYRA) Tyra Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.
Tyra Biosciences's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast TYRA's revenue for 2026 to be $557,632,807, with the lowest TYRA revenue forecast at $557,632,807, and the highest TYRA revenue forecast at $557,632,807. On average, 3 Wall Street analysts forecast TYRA's revenue for 2027 to be $2,725,113,506, with the lowest TYRA revenue forecast at $952,622,711, and the highest TYRA revenue forecast at $4,998,100,867.
In 2028, TYRA is forecast to generate $10,671,064,165 in revenue, with the lowest revenue forecast at $3,064,868,191 and the highest revenue forecast at $19,632,265,614.